Orvieto Raoul
Infertility and IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center (Tel Hashomer), Ramat Gan, 52621, Israel.
Israel and the Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, Faculty of Medical and Health Science, Tel-Aviv University, Tel Aviv, Israel.
Reprod Biol Endocrinol. 2025 Jan 23;23(Suppl 1):12. doi: 10.1186/s12958-024-01332-5.
As part of a conventional controlled ovarian hyperstimulation (COH) regimen, final follicular maturation is usually triggered by a single bolus dose of human chorionic gonadotropin (hCG). COH, which combines GnRH antagonist co-treatment with GnRH agonist(GnRHa) trigger, is often used in attempts to eliminate severe early ovarian hyperstimulation syndrome and to improve oocyte/embryo yield and quality. Recently, the combination of GnRHa, with hCG trigger has also been implemented into clinical practice. Here, we analyze and discuss published studies on various ways of triggering final follicular maturation, seeking to elucidate the appropriateness of each approach for specific patient subgroups.
作为传统控制性卵巢刺激(COH)方案的一部分,最终卵泡成熟通常由单次大剂量注射人绒毛膜促性腺激素(hCG)触发。将GnRH拮抗剂联合治疗与GnRH激动剂(GnRHa)触发相结合的COH,常用于试图消除严重的早期卵巢过度刺激综合征,并提高卵母细胞/胚胎的产量和质量。最近,GnRHa与hCG触发的联合也已应用于临床实践。在此,我们分析并讨论已发表的关于触发最终卵泡成熟的各种方式的研究,旨在阐明每种方法对特定患者亚组的适用性。